Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 5, 2003, Pages 479-483

  Vivas, Santiago ^a   Ruiz De Morales, Jose M ^a   Martinez, Julio ^a   González, Maria Cruz ^a   Martín, Sara ^a   Martín, Juan ^a   Cechini, Carlos ^a   Olcoz, Jose Luis ^a  

^a HOSPITAL DE LEÓN   (Spain)

Author keywords

Coeliac disease; Functional dyspepsia; Liver disease; Serological screening; Transglutaminase antibodies

Indexed keywords

ENDOMYSIUM ANTIBODY; ENZYME ANTIBODY; GLIADIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DUODENUM BIOPSY; DYSPEPSIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SYMPTOM;

EID: 0038740797     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000059104.41030.1c     Document Type: Article

References (27)

1. Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: a case finding study. BMJ 1999; 318:164-167.
2. Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343:200-203.
3. Ascher H, Kristiansson B. Childhood celiac disease in Sweden. Lancet 1994; 344:340-341.
4. Johnston S, Watson R, McMillan S, Sloan J, Love AH. Prevalence of coeliac diease in Northern Ireland. Lancet 1997; 350:1370.
5. Trevisiol C, Not T, Berti I, Buratti E, Citta A, Neri E, et al. Screening for coeliac disease in healthy blood donors at two immune-transfusion centers in north east Italy. Ital J Gastroenterol Hepatol 1999; 31:584-586.
6. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, Fasano A. Celiac disease risk in the USA: high prevalence of antiendomysial antibodies in healthy blood donors. Scand J Gastroenterol 1998; 33:494-498.
7. Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol 1999; 94:691-696.
8. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35:1215-1218.
9. Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J, Weinstein J. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001; 96:138-145.
10. Iltanen S, Collin P, Korpela M, Holm K, Partanen J, Polvi A, Maki M. Celiac disease and markers of celiac disease latency in patients with primary Sjogren syndrome. Am J Gastroenterol 1999; 94:1042-1046.
11. Rostaing L, Modesto A, Cisterne JM, Izopet J, Oksman F, Duffaut M, et al. Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C. Am J Nephrol 1998; 18:50-56.
12. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med 1997; 7:797-801.
13. Jennings J, Howdle P. Celiac disease. Curr Opin Gastroenterol 2001; 17:118-126.
14. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000; 18:53-81.
15. Leon F, Camarero C, R-Pena R, Eiras P, Sanchez L, Baragano M, et al. Antitransglutaminase IgA ELISA: clinical drawbacks in celiac disease diagnosis. Scand J Gastroenterol 2001; 8:849-853.
16. Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000; 95:1253-1257.
17. Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 2001; 49:506-511.
18. Riestra S, Fernandez E, Rodrigo L, Garcia S, Ocie G. Prevalence of coeliac disease in the general population of northern Spain. Scand J Gastroenterol 2000; 35:398-402.
19. Ferguson A, Arranz E, O'Mahony S. Clinical and pathological spectrum of coeliac disease: active, silent, latent, potential. Gut 1993; 34:150-151.
20. Logan RF, Tucker G, Rifkind EA, Heading RC, Ferguson A. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. BMJ 1983; 286:95-97.
21. Ciacci C, Cirillo M, Sollazzo R, Savino G, Sabbatini F, Mazzacca G. Gender and clinical presentation in adult celiac disease. Scand J Gastroenterol 1995; 30:1077-1081.
22. Bardella MT, Minoli G, Ravizza D, Radaelli F, Velio P, Quatrini M, et al. Increased prevalence of celiac disease in patients with dyspepsia. Arch Intern Med 2000; 160:1489-1491.
23. Volta U, De Franceschi L, Lari F, Molinaro N, Zoli M, Bianchi FB. Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet 1998; 352:26-29.
24. Bardella MT, Vecchi M, Conte D, Del Ninno E, Fraquelli M, Pacchetti S, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999; 29:654-657.
25. Zignego AL, Bréchot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 1999; 31:369-376.
26. Bardella M, Marino R, Meroni PL. Celiac disease during IFN treatment. Ann Intern Med 1999; 131:157-158.
27. Teml A, Vogelsang H. Re: Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001; 96:2522-2523.